(S)-4-(2-Carboxy-4-oxoazetidine-1-carboxamidomethyl)-benzenaminium 2,2,2-trifluoroacetate

ID: ALA4777693

PubChem CID: 162644198

Max Phase: Preclinical

Molecular Formula: C14H14F3N3O6

Molecular Weight: 263.25

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ccc(CNC(=O)N2C(=O)C[C@H]2C(=O)O)cc1.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C12H13N3O4.C2HF3O2/c13-8-3-1-7(2-4-8)6-14-12(19)15-9(11(17)18)5-10(15)16;3-2(4,5)1(6)7/h1-4,9H,5-6,13H2,(H,14,19)(H,17,18);(H,6,7)/t9-;/m0./s1

Standard InChI Key:  PBDSUCKUKNOMFW-FVGYRXGTSA-N

Molfile:  

     RDKit          2D

 26 26  0  0  0  0  0  0  0  0999 V2000
    5.6006   -8.0522    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    6.0134   -8.7621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4218   -8.0497    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.3076   -9.1748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7230   -9.1748    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.5973   -8.7725    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3122   -9.9949    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3454   -9.8971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3454  -10.7143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1626  -10.7143    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1626   -9.8971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7676  -11.2921    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7405  -11.2921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5290  -12.0814    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5298  -11.0806    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7405   -9.3192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5322   -9.5275    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5314   -8.5266    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1077  -11.6584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8970  -11.4469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4707  -12.0275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2594  -11.8165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4715  -11.0264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8888  -10.4474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1023  -10.6614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2606  -10.8139    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  2  1  0
  2  5  1  0
  4  6  1  0
  4  7  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11  8  1  0
  9 12  2  0
 10 13  1  0
 13 14  2  0
 13 15  1  0
 11 16  1  1
 16 17  1  0
 16 18  2  0
 15 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 23 26  1  0
M  END

Associated Targets(Human)

ITGB3 Tclin Integrin alpha-IIb/beta-3 (3481 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB1 Tclin Integrin alpha-5/beta-1 (686 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-24 (129 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEL (6614 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB3 Tclin Integrin alpha-V/beta-3 (2708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGAV Tchem Integrin alpha-V/beta-5 (589 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGAV Tchem Integrin alpha-V/beta-6 (509 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB1 Tclin Integrin alpha-4/beta-1 (2269 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGAL Tclin Integrin alpha-L/beta-2 (LFA-1) (51 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 263.25Molecular Weight (Monoisotopic): 263.0906AlogP: 0.16#Rotatable Bonds: 3
Polar Surface Area: 112.73Molecular Species: ACIDHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 3.54CX Basic pKa: 4.28CX LogP: -1.26CX LogD: -3.71
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.53Np Likeness Score: -0.50

References

1. Baiula M,Galletti P,Martelli G,Soldati R,Belvisi L,Civera M,Dattoli SD,Spampinato SM,Giacomini D.  (2016)  New β-Lactam Derivatives Modulate Cell Adhesion and Signaling Mediated by RGD-Binding and Leukocyte Integrins.,  59  (21): [PMID:27726366] [10.1021/acs.jmedchem.6b00576]

Source